A
Agenus
OrganizationHeard in 1 episode across 1 show since Jul 2026
Agenus Inc. is a biotechnology company focused on immunotherapy, including immuno-oncology, which utilizes the immune system to treat cancer. The company develops checkpoint modulators, patient-specific anti-cancer vaccines, and vaccine adjuvants.
Episodes
1
across 1 show
First heard
Jul 2026
Expert statements
1
1 positive
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 1 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
What experts have said about Agenus
1 statement · 1 positive
Agenus will use financing proceeds for colon-cancer treatment research and extend cash through 2031.
“Proceeds going to go toward finding a treatment for colon cancer and extend its cash Runway through the end of 2031.”
Open the episode · MGM and Diller; SK Hynix Lower; Agenus JumpListen at 2:40
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Agenus, newest first